Skip to main content
Have a personal or library account? Click to login
Glutathione Conjugates of Ochratoxin a as Biomarkers of Exposure /  Glutationski Konjugati Okratoksina A Kao Biomarkeri Izloženosti Cover

Glutathione Conjugates of Ochratoxin a as Biomarkers of Exposure / Glutationski Konjugati Okratoksina A Kao Biomarkeri Izloženosti

Open Access
|Jan 2013

References

  1. 1. Van der Merwe KJ, Steyn PS, Fourie L, Scott DB, Theron, JJ. Ochratoxin A, a toxic metabolite produced byWilh. Nature 1965;205:1112-3.
  2. 2. Pohland AE, Nesheim S, Friedman L. Ochratoxin A, a review. Pure Appl Chem 1992;64:1029-46.
  3. 3. Pfohl-Leszkowicz A, Manderville RA. Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res 2007;51:61-99.
  4. 4. Mally A, Dekant W. Mycotoxins and the kidney: modes of action for renal tumor formation by ochratoxin A in rodents. Mol Nutr Food Res 2009;53:467-78.
  5. 5. Kuiper-Goodman T, Hilts C, Billiard SM, Kiparissis Y, Richard IDK, Hayward S. Health risk assessment of ochratoxin A for all age-sex strata in a market economy. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2010;27:212-40.
  6. 6. International Agency for Research on Cancer (IARC). Ochratoxin A. In: Monographs on the evaluation of carcinogenic risks to humans. No. 56. Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon; IARC; 1993. p. 489-521.
  7. 7. Boorman G, editor. National Toxicology Program. Technical Report on the Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No 303-47-9) in F344/N Rats (Gavage Studies). Natl Toxicol Program Tech Rep Ser 1989;358:1-142.
  8. 8. Stoev SD. Studies on carcinogenic and toxic effects of ochratoxin A in chicks. Toxins 2010;2:649-64.
  9. 9. Krogh P, Hald B, Pleština R, Ceović S. Balkan (endemic) nephropathy and foodborne ochratoxin A: preliminary results of a survey of foodstuffs. Acta Pathol Microbiol Scand B 1977;85:238-40.
  10. 10. Grosso F, Said S, Mabrouk I, Fremy JM, Castegnaro M, Jemmali M, Dragacci S. New data on the occurrence of ochratoxin A in human sera from patients affected or not by renal diseases in Tunisia. Food Chem Toxicol 2003;41:1133-40.
  11. 11. WHO Food Additives Series 47. Safety evaluation of certain mycotoxins in food [displayed 19 September 2012]. Available at http://www.inchem.org/documents/jecfa/jecmono/v47je01. htm
  12. 12. Hibi D, Suzuki Y, Ishii Y, Jin M, Watanabe M, Sugita-Konishi Y, Yanai T, Nohmi T, Nishikawa A, Umemura T. Site-specificmutagenicity in the kidney ofdelta rats given a carcinogenic dose of ochratoxin A. Toxicol Sci 2011;122:406-14.
  13. 13. Manderville RA. A case for the genotoxicity of ochratoxin A by bioactivation and covalent DNA adduction. Chem Res Toxicol 2005;18:1091-7.
  14. 14. Pfohl-Leszkowicz A, Manderville RA. An update on direct genotoxicity as a molecular mechanism of ochratoxin A carcinogenicity. Chem Res Toxicol 2012;25:252-62.
  15. 15. Waidyanatha S, Lin PH, Rappaport SM. Characterization of chlorinated adducts of hemoglobin and albumin following administration of pentachlorophenol to rats. Chem Res Toxicol 1996;9:647-53.
  16. 16. Gillman IG, Clark TN, Manderville RA. Oxidation of ochratoxin A by an Fe-porphyrin system: model for enzymatic activation and DNA cleavage. Chem Res Toxicol 1999;12:1066-76.
  17. 17. Mally A, Zepnik H, Wanek P, Eder E, Dingley K, Ihmels H, Volkel W, Dekant W. Ochratoxin A: lack of formation of covalent DNA adducts. Chem Res Toxicol 2004;17:234-42.
  18. 18. Manderville RA, Pfohl-Leszkowicz A. Bioactivation and DNA adduction as a rationale for ochratoxin A carcinogenesis. World Mycotoxin J 2008;1:357-67.
  19. 19. Pfohl-Leszkowicz A. Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours. Arh Hig Rada Toksikol 2009;60:465-83.
  20. 20. Tozlovanu M, Faucet-Marquis V, Pfohl-Leszkowicz A, Manderville RA. Genotoxicity of the hydroquinone metabolite of ochratoxin A: structure-activity relationships for covalent DNA adduction. Chem Res Toxicol 2006;19:1241-7.
  21. 21. Dai J, Wright MW, Manderville RA. Ochratoxin A forms a carbon-bonded C8-deoxyguanosine nucleoside adduct: implications for C8 reactivity by a phenolic radical. J Am Chem Soc 2003;125:3716-7.
  22. 22. Mantle PG, Faucet-Marquis V, Manderville RA, Squillaci B, Pfohl-Leszkowicz A. Structures of covalent adducts between DNA and ochratoxin A: a new factor in debate about genotoxicity and human risk assessment. Chem Res Toxicol 2010;23:89-98.
  23. 23. Hadjeba-Medjdoub K, Tozlovanu M, Pfohl-Leszkowicz A, Frenette C, Paugh RJ, Manderville RA. Structure-activity relationships imply different mechanisms of action for ochratoxin A-mediated cytotoxicity and genotoxicity. Chem Res Toxicol 2012;25:181-90.
  24. 24. Doster RC, Sinnhuber RO. Comparative rates of hydrolysis of ochratoxins A and B. Food Cosmet Toxicol 1972;10:389-94.
  25. 25. Stander MA, Steyn PS, van der Westhuizen FH, Payne BE. A kinetic study into the hydrolysis of the ochratoxins and analogues by carboxypeptidase A. Chem Res Toxicol 2001;14:302-4.
  26. 26. Mally A, Keim-Heusler H, Amberg A, Kurz M, Zepnik H, Mantle P, Volkel W, Hard GC, Dekant W. Biotransformation and nephrotoxicity of ochratoxin B in ratsToxicol Appl Pharmacol 2005;206:43-53.
  27. 27. Castegnaro M, Canadas, D, Vrabcheva T, Petkova-Bocharova T, Chernozemsky IN, Pfohl-Leszkowicz A. Balkan endemic nephropathy: role of ochratoxins A through biomarkers. Mol Nutr Food Res 2006;50:519-29.
  28. 28. Duarte SC, Pena A, Lino CM. Human ochratoxin A biomarkers-from exposure to effect. Crit Rev Toxicol 2011;41:187-212.
  29. 29. Molinie A, Faucet V, Castegnaro M, Pfohl-Leszkowicz A. Analysis of some breakfast cereals on the French market for their contents of ochratoxin A, citrinin and fumonisin B1: development of a method for simultaneous extraction of ochratoxin A and citrinin. Food Chem 2005;92:391-400.
  30. 30. Dai J, Park G, Wright MW, Adams M, Akman SA, Manderville RA. Detection and characterization of a glutathione conjugate of ochratoxin A. Chem Res Toxicol 2002;15:1581-8.
  31. 31. Brow ME, Dai J, Park G, Wright MW, Gillman IG, Manderville RA. Photochemically catalyzed reaction of ochratoxin A with D- and L-cysteine. Photochem Photobiol 2002;76:649-56.
  32. 32. Il’ichev YV, Perry JL, Manderville RA, Chignell CF, Simon JD. The pH-dependent primary photoreactions of ochratoxin A. J Phys Chem B 2001;105:11369-76.
  33. 33. Pfohl-Leszkowicz A, Tozlovanu M, Manderville R, Peraica M, Castegnaro M, Stefanovic V. New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in Human Nephropathy and Urinary tract tumor. Mol Nutr Food Res 2007;51:1131-46.
  34. 34. Jennings-G JE, Tozlovanu M, Manderville R, Miller MS, Pfohl-Leszkowicz A, Schwartz GG. Ochratoxin A: In utero exposure in mice induces adducts in testicular DNA. Toxins 2010;2:1428-44.
  35. 35. Faucet-Marquis V, Pont F, Stormer F, Rizk T, Castegnaro M, Pfohl-Leszkowicz A. Evidence of a new dechlorinated OTA derivative formed in opossum kidney cell cultures after pretreatment by modulators of glutathione pathways. Correlation with DNA adducts formation. Mol Nutr Food Res 2006;50:531-42.
  36. 36. Dais P, Stefanaki I, Fragaki G, Mikros E. Conformational analysis of ochratoxin A by NMR spectroscopy and computational molecular modeling. J Phys Chem B 2005;109:16926-36.
  37. 37. Pfohl-Leszkowicz A, Castegnaro M. Further arguments in favour of direct covalent binding of ochratoxin A (OTA) after metabolic biotransformation. Food Addit Contam 2005;22(Suppl 1):75-87.
  38. 38. Castegnaro M, Mohr U, Pfohl-Leszkowicz A, Esteve J, Steinmann J, Tillman J, Michelon J, Bartsch H. Sex and strain-specific induction of renal tumours by ochratoxin A rats correlates with DNA adduction. Int J Cancer 1998;77:70-5.
  39. 39. Pfohl-Leszkowicz A, Pinelli E, Bartsch H, Mohr U, Castegnaro M. Sex and strain differences in ochratoxin A metabolism and DNA adduction in two strains of rats. Mol Carcinogen 1998;23:76-83.
  40. 40. Pfohl-Leszkowicz A, Bartsch H, Azemar B, Mohr U, Esteve J, Castegnaro M. MESNA protects rats against nephrotoxicity but not carcinogenicity induced by ochratoxin A, implicating two separate pathways. Facta Universitatis Ser Med Biol 2002;9:57-63.
  41. 41. Vettorazzi A, de Troconiz IF, Gonzalez-Penas E, Arbillaga L, Corcuera L-A, Gil AG, de Cerain, AL. Kidney and liver distribution of ochratoxin A in male and female F344 rats. Food Chem Toxicol 2011;49:1935-42.
  42. 42. Petkova-Bocharova T, El Adlouni C, Faucet V, Pfohl- Leszkowicz A, Mantle P. Analysis for DNA adducts, ochratoxin A content and enzymes expression in kidneys of pigs exposed to mild experimental chronic ochratoxicosis. Facta Universitatis Ser Med Biol 2003;10:111-5.
DOI: https://doi.org/10.2478/10004-1254-63-2012-2202 | Journal eISSN: 1848-6312 (formerly 0004-1254) | Journal ISSN: 0004-1254
Language: English, Croatian, Slovenian
Page range: 417 - 427
Published on: Jan 16, 2013
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services

© 2013 Mariana Tozlovanu, Delphine Canadas, Annie Pfohl-Leszkowicz, Christine Frenette, Robert J. Paugh, Richard A. Manderville, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons License.